Molecular Therapy

Molecular Therapy

分子疗法

  • 1区 中科院分区
  • Q1 JCR分区

期刊简介

《Molecular Therapy》是由Cell Press出版社于2000年创办的英文国际期刊(ISSN: 1525-0016,E-ISSN: 1525-0024),该期刊长期致力于生物工程与应用微生物领域的创新研究,主要研究方向为医学-生物工程与应用微生物。作为SCIE收录期刊(JCR分区 Q1,中科院 1区),本刊采用OA未开放获取模式(OA占比0.9816...%),以发表生物工程与应用微生物领域等方向的原创性研究为核心(研究类文章占比85.78%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在218篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Molecular Therapy审稿周期约为 约1月 。该刊近年未被列入国际预警名单,年发文量约218篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 218 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
1区
BIOTECHNOLOGY & APPLIED MICROBIOLOGY 生物工程与应用微生物 GENETICS & HEREDITY 遗传学 MEDICINE, RESEARCH & EXPERIMENTAL 医学:研究与实验
1区 1区 1区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
1区
BIOTECHNOLOGY & APPLIED MICROBIOLOGY 生物工程与应用微生物 GENETICS & HEREDITY 遗传学 MEDICINE, RESEARCH & EXPERIMENTAL 医学:研究与实验
1区 1区 1区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:BIOTECHNOLOGY & APPLIED MICROBIOLOGY SCIE Q1 4 / 174

98%

学科:GENETICS & HEREDITY SCIE Q1 5 / 191

97.6%

学科:MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q1 9 / 189

95.5%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:BIOTECHNOLOGY & APPLIED MICROBIOLOGY SCIE Q1 4 / 174

97.99%

学科:GENETICS & HEREDITY SCIE Q1 4 / 191

98.17%

学科:MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q1 6 / 189

97.09%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:19.2 SJR:3.736 SNIP:1.639
学科类别 分区 排名 百分位
大类:Pharmacology, Toxicology and Pharmaceutics 小类:Pharmacology Q1 8 / 313

97%

大类:Pharmacology, Toxicology and Pharmaceutics 小类:Drug Discovery Q1 6 / 157

96%

大类:Pharmacology, Toxicology and Pharmaceutics 小类:Genetics Q1 13 / 347

96%

大类:Pharmacology, Toxicology and Pharmaceutics 小类:Molecular Medicine Q1 9 / 178

95%

大类:Pharmacology, Toxicology and Pharmaceutics 小类:Molecular Biology Q1 24 / 410

94%

期刊发文

  • Targeting inflammatory macrophages rebuilds therapeutic efficacy of DOT1L inhibition in hepatocellular carcinoma

    Author: Yang, Yi-Bin; Wu, Cai-Yuan; Wang, Xu-Yan; Deng, Jia; Cao, Wen-Jie; Tang, Yun-Zhi; Wan, Chao-Chao; Chen, Zhi-Tian; Zhan, Wan-Yu; Shan, Hong; Kuang, Dong-Ming; Wei, Yuan

    Journal: MOLECULAR THERAPY. 2023; Vol. 31, Issue 1, pp. 105-118. DOI: 10.1016/j.ymthe.2022.09.019

  • NLRC3 expression in macrophage impairs glycolysis and host immune defense by modulating the NF-KB-NFAT5 complex during septic immunosuppression

    Author: Xu, Jiqian; Gao, Chenggang; He, Yajun; Fang, Xiangzhi; Sun, Deyi; Peng, Zhekang; Xiao, Hairong; Sun, Miaomiao; Zhang, Pei; Zhou, Ting; Yang, Xiaobo; Yu, Yuan; Li, Ruiting; Zou, Xiaojing; Shu, Huaqing; Qiu, Yang; Zhou, Xi; Yuan, Shiying; Yao, Shanglong; Shang, You

    Journal: MOLECULAR THERAPY. 2023; Vol. 31, Issue 1, pp. 154-173. DOI: 10.1016/j.ymthe.2022.08.023

  • MAP7D2 reduces CD8+cytotoxic T lymphocyte infiltration through MYH9-HMGB1 axis in colorectal cancer

    Author: Wu, Qian; Yue, Xiao; Liu, Huashan; Zhu, Yaxi; Ke, Haoxian; Yang, Xin; Yin, Shi; Li, Zhihao; Zhang, Yunfeng; Hu, Tuo; Lan, Ping; Wu, Xianrui

    Journal: MOLECULAR THERAPY. 2023; Vol. 31, Issue 1, pp. 90-104. DOI: 10.1016/j.ymthe.2022.09.001

  • CXCL11-armed oncolytic adenoviruses enhance CAR-T cell therapeutic efficacy and reprogram tumor microenvironment in glioblastoma

    Author: Wang, Guoqing; Zhang, Zongliang; Zhong, Kunhong; Wang, Zeng; Yang, Nian; Tang, Xin; Li, Hexian; Lu, Qizhong; Wu, Zhiguo; Yuan, Boyang; Zheng, Meijun; Cheng, Ping; Tong, Aiping; Zhou, Liangxue

    Journal: MOLECULAR THERAPY. 2023; Vol. 31, Issue 1, pp. 134-153. DOI: 10.1016/j.ymthe.2022.08.021

  • A novel anti-PD-L1/IL-15 immunocytokine overcomes resistance to PD-L1 blockade and elicits potent antitumor immunity

    Author: Shi, Wenqiang; Lv, Liangyin; Liu, Nan; Wang, Hui; Wang, Yang; Zhu, Wen; Liu, Zexin; Zhu, Jianwei; Lu, Huili

    Journal: MOLECULAR THERAPY. 2023; Vol. 31, Issue 1, pp. 66-77. DOI: 10.1016/j.ymthe.2022.08.016

  • Fibrotic immune microenvironment remodeling mediates superior anti-tumor efficacy of a nano-PD-L1 trap in hepatocellular carcinoma

    Author: Liu, Xiaoyu; Zhou, Jingying; Wu, Haoran; Chen, Shufen; Zhang, Lingyun; Tang, Wenshu; Duan, Liang; Wang, Ying; McCabe, Eleanor; Hu, Mengying; Yu, Zhuo; Liu, Hanzhuang; Choi, Chung Hang Jonathan; Sung, Joseph Jao-yiu; Huang, Leaf; Liu, Rihe; Cheng, Alfred Sze-lok

    Journal: MOLECULAR THERAPY. 2023; Vol. 31, Issue 1, pp. 119-133. DOI: 10.1016/j.ymthe.2022.09.012

  • NAMPT is a metabolic checkpoint of IFNy-producing CD4+T cells in lupus nephritis

    Author: Li, Mengyuan; Lai, Yimei; Chen, Binfeng; Guo, Chaohuan; Zhou, Mianjing; Zhao, Siyuan; Wang, Shuyi; Li, Jin; Yang, Niansheng; Zhang, Hui

    Journal: MOLECULAR THERAPY. 2023; Vol. 31, Issue 1, pp. 193-210. DOI: 10.1016/j.ymthe.2022.09.013

  • PD-1/PD-L1 blockade is a potent adjuvant in treatment of Staphylococcus aureus osteomyelitis in mice

    Author: Li, Kaiqun; Chen, Yuhui; Lin, Yihuang; Zhang, Guangyan; Su, Jianwen; Wu, Xiaohu; Cheng, Caiyu; Wang, Yutian; Yu, Bin; Zhang, Xianrong

    Journal: MOLECULAR THERAPY. 2023; Vol. 31, Issue 1, pp. 174-192. DOI: 10.1016/j.ymthe.2022.09.006